Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Buti

Showing results (51-60 of 335) with videos related to

Pageof 34
Sort By:
Acta Bio-Medica : Atenei Parmensis|May 8, 2015
Retroperitoneal cystoadenocarcinoma: a case report with a literature reviewDaniele Zanoni, Angelica Sikokis, Melissa Bersanelli, et al.
The Lancet. Oncology|July 4, 2014
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?Sebastiano Buti, Melissa Bersanelli, Marcello Tiseo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2014
Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecanMarcello Tiseo, Sebastiano Buti, Luca Boni, et al.
Annals of Translational Medicine|October 3, 2019
Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches"Sebastiano Buti, Alessandro Leonetti, Elisabetta Lattanzi, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Patient performance status and cancer immunotherapy efficacy: a meta-analysisMelissa Bersanelli, Matteo Brighenti, Sebastiano Buti, et al.
Oral Diseases|October 22, 2025
Lateral Deviation of the Tongue in an Otherwise Asymptomatic PatientGiulia Ghidini, Alessandro Olivari, Sebastiano Buti, et al.
Tumori|February 24, 2015
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADHPaola Bordi, Marcello Tiseo, Sebastiano Buti, et al.
Drugs in R&D|May 30, 2018
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective StudySebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2013
When a thymic carcinoma "becomes" a GISTValentina Rossi, Maddalena Donini, Pietro Sergio, et al.
Pageof 34

Showing results (51-60 of 335) with videos related to

Sort By:
Pageof 34
Acta Bio-Medica : Atenei Parmensis|May 8, 2015
Retroperitoneal cystoadenocarcinoma: a case report with a literature reviewDaniele Zanoni, Angelica Sikokis, Melissa Bersanelli, et al.
The Lancet. Oncology|July 4, 2014
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?Sebastiano Buti, Melissa Bersanelli, Marcello Tiseo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2014
Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecanMarcello Tiseo, Sebastiano Buti, Luca Boni, et al.
Annals of Translational Medicine|October 3, 2019
Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches"Sebastiano Buti, Alessandro Leonetti, Elisabetta Lattanzi, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Patient performance status and cancer immunotherapy efficacy: a meta-analysisMelissa Bersanelli, Matteo Brighenti, Sebastiano Buti, et al.
Oral Diseases|October 22, 2025
Lateral Deviation of the Tongue in an Otherwise Asymptomatic PatientGiulia Ghidini, Alessandro Olivari, Sebastiano Buti, et al.
Tumori|February 24, 2015
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADHPaola Bordi, Marcello Tiseo, Sebastiano Buti, et al.
Drugs in R&D|May 30, 2018
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective StudySebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2013
When a thymic carcinoma "becomes" a GISTValentina Rossi, Maddalena Donini, Pietro Sergio, et al.
Pageof 34